These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25906536)

  • 1. Newer cardiac biomarkers in myocardial necrosis.
    Sachdeva A; Paul B
    J Assoc Physicians India; 2014 Oct; 62(10):83-4. PubMed ID: 25906536
    [No Abstract]   [Full Text] [Related]  

  • 2. [Automated measurement of biomarkers for the diagnosis of acute myocardial infarction].
    Kovács F; Kocsis I; Varga M; Sárváry E; Bicsák G
    Orv Hetil; 2015 Jun; 156(24):964-71. PubMed ID: 26051132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using newer cardiac markers.
    Tasota FJ; Tate J
    Nursing; 2000 Dec; 30(12):28. PubMed ID: 11249430
    [No Abstract]   [Full Text] [Related]  

  • 4. Soluble lectin-like oxidized low-density lipoprotein receptor-1 as an early biomarker for ST elevation myocardial infarction: time-dependent comparison with other biomarkers: time-dependent comparison with other biomarkers.
    Kobayashi N; Hata N; Kume N; Seino Y; Inami T; Yokoyama S; Shinada T; Tomita K; Kaneshige T; Mizuno K
    Circ J; 2011; 75(6):1433-9. PubMed ID: 21467660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early positive biomarker in relation to myocardial necrosis and impaired fatty acid metabolism in patients presenting with acute chest pain at an emergency room.
    Nagahara D; Nakata T; Hashimoto A; Takahashi T; Kyuma M; Hase M; Tsuchihashi K; Shimamoto K
    Circ J; 2006 Apr; 70(4):419-25. PubMed ID: 16565558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradigm shift from myocardium-derived to plaque-derived biomarkers for very early diagnosis of acute myocardial infarction.
    Imamura T
    Circ J; 2011; 75(6):1322-3. PubMed ID: 21532186
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac troponin monitoring for detection of myocardial infarction: newer generation assays are here to stay.
    Apple FS
    Clin Chim Acta; 2007 May; 380(1-2):1-3; discussion 245-6. PubMed ID: 17306782
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac enzymes, renal failure and renal transplantation.
    Bozbas H; Yildirir A; Muderrisoglu H
    Clin Med Res; 2006 Mar; 4(1):79-84. PubMed ID: 16595795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of new serum markers for mild cardionecrosis.
    Fromm RE; Roberts R
    Curr Probl Cardiol; 2001 Apr; 26(4):241-84. PubMed ID: 11338435
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiomyocyte injury induced by hemodynamic cardiac stress: Differential release of cardiac biomarkers.
    Irfan A; Reichlin T; Twerenbold R; Fischer C; Ballarino P; Nelles B; Wildi K; Zellweger C; Rubini Gimenez M; Mueller M; Haaf P; Fischer A; Freidank H; Osswald S; Mueller C
    Clin Biochem; 2015 Dec; 48(18):1225-9. PubMed ID: 26129882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do we really need another biomarker to diagnose myocardial infarction after coronary artery bypass graft surgery?
    Rade JJ; Hogue CW
    Anesth Analg; 2010 Nov; 111(5):1086-7. PubMed ID: 20971957
    [No Abstract]   [Full Text] [Related]  

  • 12. [Detection of coronary reperfusion using biochemical markers].
    Ishii J; Nomura M
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):813-9. PubMed ID: 12436621
    [No Abstract]   [Full Text] [Related]  

  • 13. A FABP-ulous 'rule out' strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction.
    Body R; McDowell G; Carley S; Wibberley C; Ferguson J; Mackway-Jones K
    Resuscitation; 2011 Aug; 82(8):1041-6. PubMed ID: 21561701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia.
    Horacek JM; Vasatova M; Tichy M; Pudil R; Jebavy L; Maly J
    Exp Oncol; 2010 Jul; 32(2):97-9. PubMed ID: 20693970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart-type fatty acid-binding protein as a diagnostic biochemical marker for early detection of myocardial infarction.
    Hamza M; Demerdash S; Ibrahim M
    Acta Cardiol; 2016; 71(5):537-541. PubMed ID: 27695010
    [No Abstract]   [Full Text] [Related]  

  • 16. Authors' response to Apple editorial.
    Kavsak PA; MacRae AR; Lustig V; Newman AM; Ko DT; Tu JV; Palomaki GE; Jaffe AS
    Clin Chim Acta; 2007 May; 380(1-2):245-6. PubMed ID: 17328878
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory diagnosis of patients with acute chest pain.
    Penttilä I; Penttilä K; Rantanen T
    Clin Chem Lab Med; 2000 Mar; 38(3):187-97. PubMed ID: 10905753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CKMB and acute myocardial infarction in the emergency department.
    Athamneh H; Basnawi A; Siler-Fisher A
    J Emerg Med; 2013 Oct; 45(4):617-8. PubMed ID: 23623285
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison between creatine kinase MB, heart-type fatty acid-binding protein, and cardiac troponin T for detecting myocardial ischemic injury after cardiac surgery.
    Jo MS; Lee J; Kim SY; Kwon HJ; Lee HK; Park DJ; Kim Y
    Clin Chim Acta; 2019 Jan; 488():174-178. PubMed ID: 30389460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction.
    McMahon CG; Lamont JV; Curtin E; McConnell RI; Crockard M; Kurth MJ; Crean P; Fitzgerald SP
    Am J Emerg Med; 2012 Feb; 30(2):267-74. PubMed ID: 21208763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.